Innomedica
Zug
About Innomedica
Using InnoMedica’s patented technology of a highly innovative drug delivery system, active pharmaceutical agents that were previously applied systemically can now be transported selectively to the affected area and released locally. Developing a new generation of medication, for example, cancer can be treated much more effective, while at the same time side effects for patients are reduced to a minimum.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $39.7M
- Last round: Series Unknown (Nov 2021)
- Website: innomedica.comen
- Phone: +41 31 311 04 27
Industries & Categories
Alternative Medicine, Nanotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/innomedica-81749 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.